CUMBERLAND PHARMACEUTICALS INC (CPIX) › Cost of RevenueCUMBERLAND PHARMACEUTICALS INC (CPIX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $5.96M2017: $7.37M2018: $6.02M2019: $7.42M2020: $8.65M2021: $8.81M2022: $9.12M2023: $6.07M2024: $6.59M2025: $6.67M$6.67M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$6.67M+1.2%2024$6.59M+8.6%2023$6.07M-33.5%2022$9.12M+3.5%2021$8.81M+1.8%2020$8.65M+16.6%2019$7.42M+23.3%2018$6.02M-18.4%2017$7.37M+23.7%2016$5.96M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share